MARKET

NMRD

NMRD

Nemaura Medical Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.911
+0.061
+2.14%
Closed 16:00 01/28 EST
OPEN
2.870
PREV CLOSE
2.850
HIGH
2.911
LOW
2.760
VOLUME
5.38K
TURNOVER
--
52 WEEK HIGH
19.30
52 WEEK LOW
2.500
MARKET CAP
60.57M
P/E (TTM)
-1.2262
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NMRD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NMRD News

  • The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
  • Benzinga.16h ago
  • Nemaura Provides 2019 Year-End Corporate Update
  • GlobeNewswire.12/20/2019 14:00
  • The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering
  • Benzinga.12/20/2019 13:12
  • The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic
  • Benzinga.12/19/2019 12:52

More

Industry

Medical Equipment, Supplies & Distribution
+0.33%
Healthcare Equipment & Supplies
+0.58%

Hot Stocks

Name
Price
%Change

About NMRD

Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.
More

Webull offers Nemaura Medical Inc (NMRD) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.